Atjaunināt sīkdatņu piekrišanu

Coronary Stenting: Current Perspectives [Hardback]

  • Formāts: Hardback, 300 pages, weight: 835 g
  • Izdošanas datums: 30-Nov-1998
  • Izdevniecība: Informa Healthcare
  • ISBN-10: 1853176931
  • ISBN-13: 9781853176937
Citas grāmatas par šo tēmu:
  • Formāts: Hardback, 300 pages, weight: 835 g
  • Izdošanas datums: 30-Nov-1998
  • Izdevniecība: Informa Healthcare
  • ISBN-10: 1853176931
  • ISBN-13: 9781853176937
Citas grāmatas par šo tēmu:
This review of the available literature on coronary stenting identifies the indication for stent implantation and the use of adjunctive therapies which are supported by clinical evidence. The authors, both professors in the Netherlands, explain why stents are designed the way they are, what problems occur when implanting or retrieving stents, what devices can help to ensure correct stent placement, and what the clinical trials are showing. A companion to the Handbook of Coronary Stents . Distributed by Blackwell Science. Annotation c. by Book News, Inc., Portland, Or.

The sucess of coronary artery stenting is the result of improved implantation techniques, a much better understanding of the vascular response to injury, and advances in the adjunctive pharmacology. Industry has also contributed greatly by providing more versatile and user friendly stents, designed specifically to address the probelms of thrombosis and restenosis, as well as particular lesions types and clinical situations. This text covers the latest available stents, clinical trials, indications for stenting and cost considerations.
Preface ix
Historical Overview
1(16)
Stents Currently Available
17(70)
Mesh Stents
20(3)
Magic Wallstent
20(3)
Tubular stents
23(30)
Palmaz-Schatz Stents (PS-153™, Spiral™ and Crown™)
23(3)
ACS MULTI-LINK™, ACS MULTI-LINK RX DUET™`
26(2)
Radius™
28(1)
beStent™
29(1)
Tensum™ and Tenax™
30(1)
IRIS II™, SPIRAL FORCE™ and ZEBRA™
30(3)
divYsio™
33(1)
JOSTENT™ Plus, JOSTEN™ Flex
34(2)
Balloon Expandable (BX)™
36(1)
PURA-A™, PURA-VARIO™, PURA-VARIO-A™ and PURA-VARIO-Al™
36(2)
Paragon™
38(2)
V-Flex™, V-Flex Plus™
40(1)
R Stent™
40(2)
Parallel-Serial-Jang™ (PSJ-3)
42(1)
InFlow-Stent™, InFlow-Gold-Stent™
43(1)
LP-Stent™
43(3)
Seaquence™
46(1)
CIA (Coronary Improved Architecture)
47(1)
Diamond AS™, Diamond Flex AS™
47(2)
PRP-STENT™
49(1)
Terumo™
49(1)
Synthesis™
50(2)
Medtronic Self-Expanding Nitinol Stent
52(1)
Coroflex™
52(1)
CrossFlex LC™
53(1)
Coil stents
53(6)
GR II™
53(2)
Wiktor (-GX™ and -i™)
55(2)
CrossFlex™
57(1)
Freedom™ and Freedom Force™
58(1)
AngioStent™
58(1)
Ring stents
59(3)
AVE Micro Stent II™ and GFX™
59(2)
Bard XT™
61(1)
Multidesign stents
62(3)
Navius™
62(1)
Nir™ and Niroyal™
63(2)
Custom designed stents
65(22)
Randomized Clinical Trials
87(52)
Stenting compared with PTCA
87(16)
Native Vessel de-novo stenoses
87(7)
Saphenous vein graft disease
94(1)
Restenotic lesions
94(1)
Total occlusions
95(3)
Acute or threatened closure after PTCA
98(1)
Stenting in acute myocardial infarction
99(3)
Stenting compared with directional atherectomy
102(1)
Evaluation of adjunctive therapy
103(36)
Adjunctive pharmacotherapy
103(1)
Acute and subacute thrombosis
103(7)
Restenosis
110(3)
Bleeding and vascular complications
113(1)
Adjunctive rotational atherectomy
114(1)
Adjunctive Doppler flow measurement
114(1)
Adjunctive radiotherapy
114(2)
Stenting compared with surgery
116(1)
Comparison of stents
117(5)
Assessment of the role of intravascular ultrasound (IVUS)
122(3)
Assessment of the role of high-pressure stent deployment
125(1)
Comparison of access site
125(1)
Treatment of in-stent restenosis
126(1)
Stenting in small vessels
127(12)
Current Indications for Stenting
139(58)
Treatment of abrupt or threatened vessel closure during angioplasty
140(5)
Primary reduction in restenosis in de-novo focal lesions in vessels greater than 3.0 mm in diameter
145(1)
Saphenous vein graft disease
146(1)
Chronic total occlusions
147(5)
Acute myocardial infarction
152(3)
Restenotic lesions after previous balloon angioplasty
155(2)
Ostial and left main disease
157(2)
Bifurcation lesions
159(11)
Myocardial bridging
170(1)
Cardiac allograft vasculopathy
170(27)
Stent Guidance and Adjunctive Approaches
197(18)
Coronary angiography
197(1)
Role of intravascular ultrasound
198(5)
Doppler flow
203(1)
Angioscopy
204(1)
Debulking devices
204(11)
Directional coronary atherectomy (DCA)
205(1)
Rotational atherectomy
205(1)
Transluminal extraction atherectomy (TEC)
206(1)
Eximer laser coronary angioplasty (ELCA)
206(9)
Complications of Coronary Stenting
215(78)
Subacute stent thrombosis
215(78)
The problem
215(1)
Factors affecting stent thrombosis
216(4)
Device related (Surface interactions, Rheological factors) Patient-related factors (Vessel characteristics, Haemostatic predictors)
220(2)
Technique-related factors
222(4)
Prevention
226(7)
Treatment
233(1)
Restenosis
234(1)
The problem
234(3)
Risk factors
237(3)
Prevention
240(7)
Treatment
247(3)
Bleeding and vascular injury
250(1)
Stent embolization
251(1)
Side-branch occlusion
252(1)
Coronary perforation
252(1)
Infection
253(1)
Balloon rupture
253(1)
Coronary artery aneurysms
254(39)
Long-Term Follow-Up
293(4)
Cost Considerations
297(4)
Future Trends
301(2)
Appendix A List of Abbreviations 303(2)
Appendix B List of Clinical Trials 305(2)
Index 307